The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Ultrasensitive detection and tracking of circulating tumor DNA (ctDNA) and association with relapse and survival in locally advanced cervical cancer (LACC): Phase 3 CALLA trial analyses.
 
Jyoti Mayadev
Leadership - American Brachytherapy Society; NRG Oncology
Honoraria - AstraZeneca
Consulting or Advisory Role - Agenus; AstraZeneca/MedImmune; Merck; Primmune Therapeutics; Varian Medical Systems
Research Funding - varian medical systems (Inst)
Travel, Accommodations, Expenses - Merck
 
Juan Carlos Vázquez Limón
Consulting or Advisory Role - AstraZeneca/UK; Bristol-Myers Squibb
Research Funding - AstraZeneca/UK; Bristol-Myers Squibb; Janssen; Merck Sharp & Dohme; Novartis; Roche
Travel, Accommodations, Expenses - AstraZeneca/UK; Merck Sharp & Dohme; Novartis; Pfizer
 
Francisco Javier RamIrez Godinez
Consulting or Advisory Role - AstraZeneca/UK
Research Funding - AstraZeneca/UK; Janssen; Lilly; Merck Sharp & Dohme; Roche; Sanofi
Travel, Accommodations, Expenses - BioGenTech
(OPTIONAL) Uncompensated Relationships - Leadership Role at Comite de Etica e Investigacion del Hospital Civil de Guadalajara
 
Manuel Leiva
Honoraria - Roche
Consulting or Advisory Role - Roche
Research Funding - AstraZeneca/UK; Bristol-Myers Squibb; Merck Sharp & Dohme; Roche
Travel, Accommodations, Expenses - Roche
 
Lucely Del Carmen Cetina
Honoraria - AstraZeneca/UK; Merck; Roche
Consulting or Advisory Role - AstraZeneca/UK; Lilly; Merck; Roche
Research Funding - AstraZeneca/UK; Lilly; Roche
 
Szilvia Varga
No Relationships to Disclose
 
Alejandro Molina Alavez
Honoraria - Amgen; AstraZeneca; GlaxoSmithKline; Lilly; Roche
Consulting or Advisory Role - GlaxoSmithKline; Lilly
Research Funding - Amgen; Arcus Biosciences; AstraZeneca; Bayer; BioNTech; Bristol-Myers Squibb; Gilead Sciences; Janssen; Johnson & Johnson; Lilly; Merck Sharp & Dohme; Novartis; Regeneron
Travel, Accommodations, Expenses - Asofarma; AstraZeneca; Bristol-Myers Squibb; Eisai; GlaxoSmithKline; Ipsen; Lilly; Merck Sharp & Dohme; Sanofi/Aventis
 
Ashley Alarcon-Rozas
No Relationships to Disclose
 
Natalia Valdivieso
Consulting or Advisory Role - Johnson & Johnson/Janssen
Speakers' Bureau - AstraZeneca
 
Xiaohua Wu
No Relationships to Disclose
 
Masaki Mandai
No Relationships to Disclose
 
Ronnie Shapira-Frommer
Honoraria - AstraZeneca/UK; Bristol-Myers Squibb; Medison; Merck Sharp & Dohme; NeoPharm; Novartis; Roche
Consulting or Advisory Role - Merck Sharp & Dohme
Research Funding - Merck Sharp & Dohme
 
Maria Estevez-Diz
Consulting or Advisory Role - AstraZeneca/UK
Research Funding - AstraZeneca/UK
 
Sewanti Limaye
Honoraria - AstraZeneca/UK; Boehringer Ingelheim; Bristol-Myers Squibb; Merck; Novartis; Roche
Consulting or Advisory Role - AstraZeneca/UK; Boehringer Ingelheim; Bristol-Myers Squibb; Merck; Novartis; Roche
Speakers' Bureau - AstraZeneca/UK; Boehringer Ingelheim; Bristol-Myers Squibb; Merck; Novartis; Roche
 
Wenjing Xin
Employment - AstraZeneca/UK
Stock and Other Ownership Interests - AstraZeneca/UK
 
Maria Broggi
Employment - AstraZeneca/UK
Stock and Other Ownership Interests - AstraZeneca/UK
 
Daniel Yuan
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Ross Stewart
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Bradley Monk
Honoraria - Abbvie; AstraZeneca; BioNTech SE; Corcept Therapeutics; DSI; Eisai; Genmab; Genmab/Seagen; GlaxoSmithKline; GOG Foundation; Immunogen; Incyte; Karyopharm Therapeutics; Lilly; Merck; Mersana; Mural; Myriad Genetics; Natera; Novartis; Novocure; Onco4; Panavance Therapeutics; Pharma&; ProfoundBio; Regeneron; Roche/Genentech; Sutro Biopharma; Tubulis GmbH; Verastem; Zentalis; Zymeworks
Consulting or Advisory Role - Abbvie; Alkermes; AstraZeneca; BioNTech SE; Corcept Therapeutics; DSI; Eisai; Genmab/Seattle Genetics; GOG Foundation; Gradalis; ImmunoGen; Incyte; Karyopharm Therapeutics; Lilly; Merck; Mersana; Myriad Pharmaceuticals; Natera; Novartis; Novocure; OncoC4; Panavance Therapeutics; Pharma&; ProfoundBio; Regeneron; Roche/Genentech; Sutro Biopharma; Tubulis GmbH; Verastem; Zentalis; Zymeworks
Speakers' Bureau - AstraZeneca; Eisai; Immunogen/Abbvie; Lilly; Merck; TESARO/GSK
Research Funding - Advaxis (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Genentech (Inst); Immunogen (Inst); Janssen (Inst); Lilly (Inst); Morphotek (Inst); Novartis (Inst); Nucana (Inst); Pfizer (Inst); Regeneron (Inst); Tesaro (Inst)